Recommended videos you might also like
07:46
The place of atherectomy and DCB
![](https://reachora-public-videos.imgix.net/v/10/a/5/a9a26c-43fd-4c54-a72c-d6133b553bdb/thumbnails/image_1.jpg)
05:20
CX Debate: Common femoral and profunda femoris artery disease are best manage...
![](https://reachora-public-videos.imgix.net/v/10/4/7/29889d-f3e8-431e-988b-36177c2965f4/thumbnails/image_1.jpg)
29:37
Complex severe iliac occlusive disease-treatment algorithm and treatment gaps
![](https://reachora-public-videos.imgix.net/v/10/9/f/782fcb-5201-4dfc-8271-50bbeec1185b/thumbnails/image_1.jpg)
04:23
Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB)
![](https://reachora-public-videos.imgix.net/v/10/7/9/132978-c7ce-4a38-811c-8252d48242cc/thumbnails/image_1.jpg)
06:07
The cost of emergency peripheral events for the patient and the health service
![](https://reachora-public-videos.imgix.net/v/10/9/f/5c3463-9cca-4847-9b41-e967c97adb50/thumbnails/image_1.jpg)
07:30
Audience participation and discussion
![](https://reachora-public-videos.imgix.net/v/10/2/2/e02853-4946-46e4-bae4-06af56ef0530/thumbnails/image_1.jpg)
CX Great Debate: Endovascular first for critical limb ischaemia is a concept without evidence - For the motion
Speakers
A vascular surgeon at Brigham and Women's Hospital, Boston, MA, USA. Features in 3 videos on Wondr Medical. Matthew...
Read More
A vascular surgeon at Brigham and Women's Hospital, Boston, MA, USA. Features in 3 videos on Wondr Medical. Matthew Menard generally speaks on Peripheral Vascular Disease (PVD).
Show Less
Related Videos
![](https://reachora-public-videos.imgix.net/v/10/a/a/de5b5c-9230-4085-a45a-65dc4eef0ec3/thumbnails/image_1.jpg)
Not always endovascular first - the BEST trial
30 Aug 2018
![](https://reachora-public-videos.imgix.net/v/10/5/5/492128-f343-4c82-9f2b-d20935a3b44b/thumbnails/image_1.jpg)
IN.PACT Global-severe SFA lesions
30 Aug 2018
![](https://reachora-public-videos.imgix.net/v/10/4/a/e99027-6f06-41c0-a7bd-39ec07235929/thumbnails/image_1.jpg)
Audience participation and discussion
30 Aug 2018
Start a conversation